Monomorphic Ventricular Arrhythmias in Athletes

Hsu, Jeffrey J.; Nsair, Ali; Aboulhosn, Jamil; Horwich, Tamara B.; Dave, Ravi H.; Shannon, Kevin; Boyle, Noel G.; Shivkumar, Kalyanam; Bradfield, Jason S.

doi:10.15420/aer.2019.19.3

Cited by 4 publications

(1 citation statement)

References 62 publications

(95 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…17 ARVC is a common cause of sudden cardiac death (SCD) in athletes. 18 This review focuses on mechanisms underlying ARVC and how they relate to the clinical presentation and diagnostic criteria. In addition, all aspects of the clinical management of ARVC will be addressed.…”

Section: Introductionmentioning

confidence: 99%

<p>Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Mechanisms and Management</p>

AlTurki¹,

Alotaibi²,

Joza³

et al. 2020

RRCC

View full text Add to dashboard Cite

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a primary cardiac myocytes disorder that predominantly affects the right ventricle. It is mainly inherited as autosomal dominant with variable expressivity; it also has been recognized as one of the major genetic causes of sudden cardiac death in the young and in athletes. The desmosomal protein is the most commonly affected structure and around 60% of diagnosed cases have an identified genetic mutation. ARVC is characterized histologically by the replacement of cardiomyocytes with fibro-fatty tissue that is progressive over time. The most commonly involved sites in the heart are right ventricle inflow tract, right ventricular outflow tract and posterolateral wall of the left ventricle. New diagnostic criteria have increased the sensitivity and specificity for ARVC/D. These include imaging evidence of RV regional wall motion abnormalities and RV dilatation using echocardiography, cardiac magnetic resonance imaging and angiography. Other diagnostic criteria include fibrous replacement of the RV-free wall on biopsy, repolarization and conduction abnormalities on the electrocardiogram as well as ventricular tachyarrhythmias and significant family history. Management involves assessing for implantable-cardioverter implantation, pharmacological therapy for prevention of ventricular arrhythmias and treatment of any ventricular dysfunction. Patients with ARVC/D who are engaged in strenuous/endurance/competitive physical activity have 2-5-fold increased risk of sudden cardiac death and restriction from competitive/endurance sports is important. Family screening is important to identify asymptomatic patients.

show abstract

Section: Introductionmentioning

confidence: 99%

<p>Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Mechanisms and Management</p>

AlTurki¹,

Alotaibi²,

Joza³

et al. 2020

RRCC

View full text Add to dashboard Cite

show abstract

Premature ventricular contractions (PVCs) in young athletes

Gomez¹,

Hwang²,

Kim³

et al. 2022

Progress in Cardiovascular Diseases

View full text Add to dashboard Cite

Consumer wearable technologies to identify and monitor exercise-related arrhythmias in athletes

Sanchís-Gomar

Lavie

Pérez

2020

Current Opinion in Cardiology

View full text Add to dashboard Cite

Purpose of review The aim of this study was to synthesize the current evidence supporting and against the use of wearable devices to detect underlying heart conditions in athletes and the most significant limitations. Recent findings Although several large studies have been conducted to evaluate the ability of wearables devices to identify atrial fibrillation among the general population, no studies evaluating their ability to detect other exercise-related arrhythmias in athletes are very sparse. Most of the studies or case reports are focused on the wearables’ reliability and accuracy compared with standard ECG. Only small studies evaluating the accuracy of one wearable device in athletes have been carried out to date. Unfortunately, none of them have investigated their ability to detect specific arrhythmias in the athletic population. Summary Rapidly detecting dangerous arrhythmias in a symptomatic athlete continues to be an elusive goal. The use of smartphone ECG monitors can provide diagnostic data in athletes with symptoms that could represent a helpful instrument. However, many uncertainties remain and need to be addressed and validated in large-scale trials to incorporate these devices into the healthcare system and be part of an athlete's daily monitoring and healthcare.

show abstract

Monomorphic Ventricular Arrhythmias in Athletes

Cited by 4 publications

References 62 publications

<p>Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Mechanisms and Management</p>

<p>Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Mechanisms and Management</p>

Premature ventricular contractions (PVCs) in young athletes

Consumer wearable technologies to identify and monitor exercise-related arrhythmias in athletes

Contact Info

Product

Resources

About